To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Open-Label Placebo Administration in Elderly Patients With Symptomatic Knee Osteoarthritis

Download
Share
Reprints
Cite This
About
+ Favorites
Download
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
July 2022

Open-Label Placebo Administration in Elderly Patients With Symptomatic Knee Osteoarthritis

Vol: 270| Issue: 1| Number:2| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Open-Label Placebo Administration Decreases Pain in Elderly Patients With Symptomatic Knee Osteoarthritis - A Randomized Controlled Trial

Front Psychiatry. 2022 01-May;():. 10.3389/fpsyt.2022.853497

Contributing Authors:
E Olliges S Stroppe A Haile F Reiß M Malhis SA Funke K Meissner

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Sixty-one patients with knee osteoarthritis were randomized to receive an open-label placebo with verbal suggestions indicating pain relief (n=21) or mood improvement (n=21), or no treatment (n=19). The primary outcomes of interest included knee pain and function (Numeric Rating Scale [NRS]; Western Ontario and McMaster Universities Osteoarthritis Index [WOMAC]). Secondary outcomes of interest inc...

Join the Conversation

Please Login or Join to leave comments.